Literature DB >> 24649280

Serological and histological indices of hepatocellular carcinoma and tumor volume doubling time.

Naoki Shingaki1, Hideyuki Tamai1, Yoshiyuki Mori1, Kosaku Moribata1, Shotaro Enomoto1, Hisanobu Deguchi1, Kazuki Ueda1, Izumi Inoue1, Takao Maekita1, Mikitaka Iguchi1, Jun Kato1, Masao Ichinose1.   

Abstract

Hepatocellular carcinoma (HCC) frequently develops in cirrhotic liver and is one of the most common malignancies worldwide. The tumor volume doubling time (TVDT) reflects the natural tumor growth rate and is an indicator of the biological malignant potential of a tumor. The present study aimed to elucidate the association between the serological and histological indices of HCC and TVDT. TVDT was analyzed for 53 HCCs by measuring the enlargement of the tumor diameter on dynamic computed tomography. Differences in TVDT were compared among histological grades of HCC differentiation. The α-fetoprotein (AFP) doubling time (T2AFP) for 44 HCCs with AFP levels >200 ng/ml was calculated and the differences in T2AFP were compared according to the histological grade of HCC differentiation and positivity for Lens culinaris agglutinin-reactive fraction of α-fetoprotein (AFP-L3). Among these 44 HCCs, the correlation between T2AFP and TVDT was analyzed for the 27 tumors for which TVDT could be calculated. The mean ± standard deviation (SD) TVDT in Edmondson grade 1 (Ed1), Ed2 and Ed3 HCC was 138.3±110.3, 94.9±91.5 and 32.2±20.8 days, respectively (P<0.05). The mean ± SD T2AFP in Ed2 and Ed3 HCC was 121.0±167.5 and 37.3±24.6 days, respectively (P<0.01). TVDT and T2AFP decreased with histological dedifferentiation of HCC. The mean ± SD T2AFP in the AFP-L3-positive and -negative groups was 63.2±101.2 and 191.9±209.9 days, respectively, with a statistically significant difference between the groups (P<0.01). A significant correlation was observed between T2AFP and TVDT (correlation coefficient, 0.70; P<0.01). A significant correlation was also observed among TVDT, serological indices and histological grades of HCC differentiation. A short T2AFP and/or AFP-L3-positivity were shown to reflect a poorly differentiated HCC histopathology and a higher malignant potential.

Entities:  

Keywords:  hepatocellular carcinoma; histological differentiation; tumor volume doubling time; α-fetoprotein; α-fetoprotein doubling time

Year:  2013        PMID: 24649280      PMCID: PMC3916198          DOI: 10.3892/mco.2013.186

Source DB:  PubMed          Journal:  Mol Clin Oncol        ISSN: 2049-9450


  22 in total

1.  Primary carcinoma of the liver: a study of 100 cases among 48,900 necropsies.

Authors:  H A EDMONDSON; P E STEINER
Journal:  Cancer       Date:  1954-05       Impact factor: 6.860

2.  Relationship between Lens culinaris agglutinin-reactive alpha-fetoprotein and pathologic features of hepatocellular carcinoma.

Authors:  Toshifumi Tada; Takashi Kumada; Hidenori Toyoda; Seiki Kiriyama; Yasuhiro Sone; Makoto Tanikawa; Yasuhiro Hisanaga; Shusuke Kitabatake; Teiji Kuzuya; Koji Nonogaki; Junichi Shimizu; Akihiro Yamaguchi; Masatoshi Isogai; Yuji Kaneoka; Junji Washizu; Shinji Satomura
Journal:  Liver Int       Date:  2005-08       Impact factor: 5.828

3.  Lens culinaris agglutinin-reactive alpha-fetoprotein and protein induced by vitamin K absence II are potential indicators of a poor prognosis: a histopathological study of surgically resected hepatocellular carcinoma.

Authors:  Hisamitsu Miyaaki; Osamu Nakashima; Mina Kurogi; Katsumi Eguchi; Masamichi Kojiro
Journal:  J Gastroenterol       Date:  2007-12-25       Impact factor: 7.527

4.  Relationship between alpha-fetoprotein serum levels, tumour volume and growth rate of hepatocellular carcinoma in a western population.

Authors:  L Bolondi; G Benzi; V Santi; S Gaiani; S L Li Bassi; G Zironi; A Mazziotti; C Sama; W Grigioni; G Gozzetti
Journal:  Ital J Gastroenterol       Date:  1990-08

5.  Clinicopathologic features and prognostic factors of resected solitary small-sized hepatocellular carcinoma.

Authors:  Saburo Fukuda; Toshiyuki Itamoto; Hideki Nakahara; Toshihiko Kohashi; Hideki Ohdan; Hiroshi Hino; Makoto Ochi; Hirotaka Tashiro; Toshimasa Asahara
Journal:  Hepatogastroenterology       Date:  2005 Jul-Aug

6.  Growth rate of asymptomatic hepatocellular carcinoma and its clinical implications.

Authors:  J C Sheu; J L Sung; D S Chen; P M Yang; M Y Lai; C S Lee; H C Hsu; C N Chuang; P C Yang; T H Wang
Journal:  Gastroenterology       Date:  1985-08       Impact factor: 22.682

7.  Natural course of small hepatocellular carcinoma with underlying cirrhosis. A study of 30 patients.

Authors:  M Ebara; R Hatano; H Fukuda; M Yoshikawa; N Sugiura; H Saisho
Journal:  Hepatogastroenterology       Date:  1998-08

8.  Natural history of small untreated hepatocellular carcinoma in cirrhosis: a multivariate analysis of prognostic factors of tumor growth rate and patient survival.

Authors:  L Barbara; G Benzi; S Gaiani; F Fusconi; G Zironi; S Siringo; A Rigamonti; C Barbara; W Grigioni; A Mazziotti
Journal:  Hepatology       Date:  1992-07       Impact factor: 17.425

9.  Preoperative tumor marker doubling time is a useful predictor of recurrence and prognosis after hepatic resection of hepatocellular carcinoma.

Authors:  Toshiro Masuda; Toru Beppu; Kei Horino; Hiroyuki Komori; Hiromitsu Hayashi; Hirohisa Okabe; Ryu Otao; Hasita Horlad; Takatoshi Ishiko; Hiroshi Takamori; Ken Kikuchi; Hideo Baba
Journal:  J Surg Oncol       Date:  2010-10-01       Impact factor: 3.454

10.  Prognostic significance of Lens culinaris agglutinin A-reactive alpha-fetoprotein in small hepatocellular carcinomas.

Authors:  F Yamashita; M Tanaka; S Satomura; K Tanikawa
Journal:  Gastroenterology       Date:  1996-10       Impact factor: 22.682

View more
  4 in total

Review 1.  Evidence Supporting LI-RADS Major Features for CT- and MR Imaging-based Diagnosis of Hepatocellular Carcinoma: A Systematic Review.

Authors:  An Tang; Mustafa R Bashir; Michael T Corwin; Irene Cruite; Christoph F Dietrich; Richard K G Do; Eric C Ehman; Kathryn J Fowler; Hero K Hussain; Reena C Jha; Adib R Karam; Adrija Mamidipalli; Robert M Marks; Donald G Mitchell; Tara A Morgan; Michael A Ohliger; Amol Shah; Kim-Nhien Vu; Claude B Sirlin
Journal:  Radiology       Date:  2017-11-21       Impact factor: 11.105

2.  Histology of Hepatocellular Carcinoma: Association with Clinical Features, Radiological Findings, and Locoregional Therapy Outcomes.

Authors:  Benjamin V Park; Ron C Gaba; Yu-Hui Huang; Yi-Fan Chen; Grace Guzman; R Peter Lokken
Journal:  J Clin Imaging Sci       Date:  2019-11-18

3.  Hepatocellular carcinoma tumour volume doubling time: a systematic review and meta-analysis.

Authors:  Piyush Nathani; Purva Gopal; Nicole Rich; Adam Yopp; Takeshi Yokoo; Binu John; Jorge Marrero; Neehar Parikh; Amit G Singal
Journal:  Gut       Date:  2020-05-12       Impact factor: 23.059

Review 4.  CT/MRI LI-RADS v2018 vs. CEUS LI-RADS v2017-Can Things Be Put Together?

Authors:  Cosmin Caraiani; Bianca Boca; Vlad Bura; Zeno Sparchez; Yi Dong; Christoph Dietrich
Journal:  Biology (Basel)       Date:  2021-05-06
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.